TraceIT Tissue Marker to Mark the Primary Resection Bed Margins of Oropharyngeal Cancers
Condition(s):Oropharyngeal CancerLast Updated:July 12, 2022Terminated
Hide Studies Not Open or Pending
Condition(s):Oropharyngeal CancerLast Updated:July 12, 2022Terminated
Condition(s):Oropharyngeal CancerLast Updated:July 27, 2018Unknown status
Condition(s):Oropharyngeal CancerLast Updated:February 3, 2023Active, not recruiting
Condition(s):Oropharyngeal CancerLast Updated:May 17, 2023Active, not recruiting
Condition(s):HPV; Oropharyngeal CancerLast Updated:December 7, 2022Not yet recruiting
Condition(s):Oropharynx CancerLast Updated:May 11, 2023Active, not recruiting
Condition(s):Oropharynx CancerLast Updated:August 11, 2022Recruiting
Condition(s):Oropharyngeal CancerLast Updated:August 30, 2022Active, not recruiting
Condition(s):Oropharynx CancerLast Updated:March 15, 2023Recruiting
Condition(s):Oropharyngeal Cancer; Human Papillomavirus-Related CarcinomaLast Updated:October 4, 2021Completed
At TrialBulletin.com, we keep tabs on over 200,000 clinical trials in the US and abroad, using medical data supplied directly by the US National Institutes of Health. Please see the About and Contact page for details.